 |
 |
|
|
|
| Rimonabant Powder (SR141716) |
 |
| C22H21Cl3N4O |
 |
| 168273-06-1 |
 |
Rimonabant Powder is a pharmaceutical substance that gained attention for its potential use in the medical field.It belongs to a class of drugs known as selective cannabinoid receptor antagonists.Rimonabant was initially developed as an anti-obesity medication,targeting the endocannabinoid system to help regulate appetite and weight.
The Powder form of Rimonabant allows for easy handling and dispersion during formulation processes.Rimonabant Powder is sparingly soluble in water,which means it has limited solubility in aqueous solutions.However,it can exhibit better solubility in organic solvents such as ethanol,methanol,or propylene glycol.The solubility characteristics of Rimonabant are important considerations during formulation development.
Benefits:
1.Appetite Suppression
Rimonabant was designed to reduce appetite and promote weight loss by blocking the CB1 receptors in the brain involved in appetite regulation.By inhibiting these receptors,Rimonabant aimed to decrease feelings of hunger and cravings,helping individuals control their food intake.
2.Weight Loss
As a result of appetite suppression,Rimonabant was expected to lead to weight loss in individuals with obesity or overweight.Clinical trials showed that Rimonabant treatment could result in significant weight reduction when combined with a controlled diet and exercise.
3.Metabolic Improvements
Rimonabant exhibited potential benefits in improving metabolic parameters associated with obesity,such as lipid profiles,insulin resistance,and markers of cardiovascular risk.It aimed to promote positive changes in these metabolic factors,which are often compromised in individuals with excess weight.
4.Smoking Cessation Aid
Rimonabant was investigated for its potential use as an aid in smoking cessation.It was thought that by blocking the CB1 receptors,Rimonabant could reduce nicotine cravings and withdrawal symptoms,supporting individuals in their efforts to quit smoking. |
 |
medical use
|
 |
Molecular Weight: 463.8
Melt Point: 230 ¡ÆC –
240 ¡ÆC
Color: Grey-white powder |
| Industrial field |
pharmaceutical |
|
|
 |
 |
|
AASraw/Aea.ltd
|
| Phone |
+13204026693 |
| Fax |
|
| Homepage |
- |
| E-mail |
King@aea.ltd
|
| Address |
FLAT/RM C1 4/F SUMMIT BUILDING 30 MAN YUE STREET HUNG HOM,HONG KONG,CHINA |
|
 |
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
|
|
|
|
